HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.

Abstract
Measles virus (MV) infects CD150Tg/Ifnar (IFN alpha receptor)(-/-) mice but not CD150 (a human MV receptor)-transgenic (Tg) mice. We have shown that bone marrow-derived dendritic cells (BMDCs) from CD150Tg/Ifnar(-/-) mice are permissive to MV in contrast to those from simple CD150Tg mice, which reveals a crucial role of type I interferon (IFN) in natural tropism against MV. Yet, the mechanism whereby BMDCs produce initial type I IFN has not been elucidated in MV infection. RNA virus infection usually allows cells to generate double-stranded RNA and induce activation of IFN regulatory factor (IRF) 3/7 transcription factors, leading to the production of type I IFN through the retinoic acid-inducible gene I (RIG-I)/melanoma differentiation-associated gene 5 (MDA5)-mitochondrial antiviral signaling protein (MAVS) pathway. In mouse experimental BMDCs models, we found CD150Tg/Mavs(-/-)BMDCs, but not CD150Tg/Irf3(-/-)/Irf7(-/-)BMDCs, permissive to MV. IFN-α/β were not induced in MV-infected CD150Tg/Mavs(-/-)BMDCs, while IFN-β was subtly induced in CD150Tg/Irf3(-/-)/Irf7(-/-)BMDCs. In vivo systemic infection was therefore established by transfer of MV-infected CD150Tg/Mavs(-/-) BMDCs to CD150Tg/Ifnar(-/-) mice. These data indicate that MAVS-dependent, IRF3/7-independent IFN-β induction triggers the activation of the IFNAR pathway so as to restrict the spread of MV by infected BMDCs. Hence, MAVS participates in the initial induction of type I IFN in BMDCs and IFNAR protects against MV spreading. We also showed the importance of IL-10-producing CD4(+) T cells induced by MV-infected BMDCs in vitro, which may account for immune modulation due to the functional aberration of DCs.
AuthorsHiromi Takaki, Kenya Honda, Koji Atarashi, Fukiko Kobayashi, Takashi Ebihara, Hiroyuki Oshiumi, Misako Matsumoto, Masashi Shingai, Tsukasa Seya
JournalMolecular immunology (Mol Immunol) Vol. 57 Issue 2 Pg. 100-10 (Feb 2014) ISSN: 1872-9142 [Electronic] England
PMID24096085 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Adaptor Proteins, Signal Transducing
  • Adaptor Proteins, Vesicular Transport
  • Antigens, CD
  • IPS-1 protein, mouse
  • Interferon Regulatory Factor-3
  • Interferon Regulatory Factor-7
  • Irf7 protein, mouse
  • Receptors, Cell Surface
  • SLAMF1 protein, human
  • TICAM-1 protein, mouse
  • Interleukin-10
  • Receptor, Interferon alpha-beta
  • Signaling Lymphocytic Activation Molecule Family Member 1
  • Interferon-beta
  • Ddx58 protein, mouse
  • Ifih1 protein, mouse
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases
  • Interferon-Induced Helicase, IFIH1
Topics
  • Adaptor Proteins, Signal Transducing (deficiency, genetics, metabolism)
  • Adaptor Proteins, Vesicular Transport (deficiency, genetics)
  • Animals
  • Antigens, CD (metabolism)
  • Bone Marrow Cells (cytology)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Line
  • Chlorocebus aethiops
  • DEAD Box Protein 58
  • DEAD-box RNA Helicases (metabolism)
  • Dendritic Cells (cytology, immunology)
  • Interferon Regulatory Factor-3 (deficiency, genetics, metabolism)
  • Interferon Regulatory Factor-7 (deficiency, genetics, metabolism)
  • Interferon-Induced Helicase, IFIH1
  • Interferon-beta (biosynthesis, metabolism)
  • Interleukin-10 (metabolism)
  • Measles (immunology)
  • Measles virus (immunology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptor, Interferon alpha-beta (genetics)
  • Receptors, Cell Surface (metabolism)
  • Signal Transduction (immunology)
  • Signaling Lymphocytic Activation Molecule Family Member 1
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: